The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Durgam Suresh K. since 2021.
This trader's CIK number is 1829958.
At the time of last reporting, Durgam Suresh K. was the EVP, Chief Medical Officer of Intra-cellular Therapies, Inc.. (stock ticker symbol ITCI).
Also see all insider trading activities at Intra-cellular Therapies, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ITCI | 0 | $0 | 0 | $0 | 29,220 | $0 |
| 2024 | ITCI | 0 | $0 | 82,723 | $5,798,387 | 90,666 | $1,237,543 |
| 2023 | ITCI | 0 | $0 | 46,708 | $2,603,564 | 23,604 | $0 |
| 2022 | ITCI | 0 | $0 | 29,353 | $1,434,599 | 29,353 | $0 |
| 2021 | ITCI | 0 | $0 | 7,101 | $245,985 | 21,446 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-03-06 | ITCI | Option Ex | 13,133 | .00 | 0 |
| 2025-03-10 | ITCI | Option Ex | 7,345 | .00 | 0 |
| 2025-03-01 | ITCI | Option Ex | 8,742 | .00 | 0 |
| 2024-03-11 | ITCI | Sale | 3,712 | 65.97 | 244,880 |
| 2024-03-07 | ITCI | Sale | 6,450 | 66.60 | 429,569 |
| 2024-03-10 | ITCI | Option Ex | 7,345 | .00 | 0 |
| 2024-03-06 | ITCI | Option Ex | 13,132 | .00 | 0 |
| 2024-02-23 | ITCI | Option Ex | 7,907 | .00 | 0 |
| 2024-02-26 | ITCI | Sale | 4,112 | 70.19 | 288,608 |
| 2024-02-02 | ITCI | Sale | 6,167 | 67.09 | 413,744 |
| 2024-01-02 | ITCI | Option Ex | 62,282 | 19.87 | 1,237,543 |
| 2024-01-02 | ITCI | Sale | 62,282 | 70.99 | 4,421,586 |
| 2023-12-13 | ITCI | Sale | 21,262 | 65.00 | 1,382,030 |
| 2023-07-17 | ITCI | Sale | 1,842 | 65.00 | 119,730 |
| 2023-03-10 | ITCI | Option Ex | 7,344 | .00 | 0 |
| 2023-03-13 | ITCI | Sale | 7,344 | 44.69 | 328,166 |
| 2023-02-23 | ITCI | Option Ex | 7,906 | .00 | 0 |
| 2023-02-24 | ITCI | Sale | 7,906 | 47.14 | 372,688 |
| 2023-02-21 | ITCI | Sale | 8,354 | 47.99 | 400,950 |
| 2023-02-18 | ITCI | Option Ex | 8,354 | .00 | 0 |
| 2022-03-02 | ITCI | Sale | 4,177 | 56.98 | 238,005 |
| 2022-03-04 | ITCI | Sale | 3,860 | 55.52 | 214,307 |
| 2022-02-23 | ITCI | Option Ex | 7,906 | .00 | 0 |
| 2022-02-24 | ITCI | Sale | 4,046 | 52.17 | 211,067 |
| 2022-02-18 | ITCI | Option Ex | 8,354 | .00 | 0 |
| 2022-02-22 | ITCI | Sale | 4,177 | 55.16 | 230,424 |
| 2022-01-18 | ITCI | Sale | 6,223 | 42.03 | 261,552 |
| 2022-01-10 | ITCI | Sale | 6,870 | 40.65 | 279,244 |
| 2022-01-08 | ITCI | Option Ex | 13,093 | .00 | 0 |
| 2021-02-18 | ITCI | Option Ex | 8,354 | .00 | 0 |
| 2021-02-19 | ITCI | Sale | 2,734 | 39.08 | 106,831 |
| 2021-01-08 | ITCI | Option Ex | 13,092 | .00 | 0 |
| 2021-01-11 | ITCI | Sale | 4,367 | 31.86 | 139,154 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Durgam Suresh K. (EVP, Chief Medical Officer of Intra-cellular Therapies, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.